Human Kruppel-related 3 (HKR3): A candidate for the 1p36 neuroblastoma tumour suppressor gene?

European Journal of Cancer

Volumn 33, Issue 12, 1997, Pages 1991-1996

  Maris, J M ^a   Jensen, J ^a   Sulman, E P ^a   Beltinger, C P ^a   Allen, C ^a   Biegel, J A ^a   Brodeur, G M ^a   White, P S ^a  

^a CHILDREN S HOSPITAL OF PHILADELPHIA   (United States)

Author keywords

Chromosomes; Human; Pair 1; chromosome mapping; genes; Suppressor; Tumour; molecular sequence data; mutation; neuroblastoma (genetics); transcription factors; zinc fingers

Indexed keywords

TRANSCRIPTION FACTOR; ZINC FINGER PROTEIN;

CHROMOSOME 1P; CHROMOSOME MAP; CONFERENCE PAPER; GENE DELETION; GENE MUTATION; GENETIC LINKAGE; GENETICS; HUMAN; HUMAN CELL; MOLECULAR CLONING; MOLECULAR GENETICS; MULTIGENE FAMILY; NEUROBLASTOMA; OPEN READING FRAME; PRIORITY JOURNAL; SEQUENCE HOMOLOGY; TUMOR SUPPRESSOR GENE; ADULT; ARTICLE; CELL CULTURE; CHROMOSOME 1; CHROMOSOME DELETION; HETEROZYGOSITY LOSS; METABOLISM; MUTATION;

ADULT; CHROMOSOME DELETION; CHROMOSOME MAPPING; CHROMOSOMES, HUMAN, PAIR 1; GENES, TUMOR SUPPRESSOR; HUMANS; LOSS OF HETEROZYGOSITY; MUTATION; NEUROBLASTOMA; TUMOR CELLS, CULTURED; ZINC FINGERS;

EID: 0031283006     PISSN: 09598049     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0959-8049(97)00279-7     Document Type: Conference Paper

References (35)

1. White PS, Maris JM, Beltinger C, et al. A region of consistent deletion in neuroblastoma maps within human chromosome 1p36.2-36.3. Proc Natl Acad Sci USA 1995, 92, 5520-5524.
2. Maris JM, White PS, Beltinger CP, et al. Significance of chromosome 1p loss of heterozygosity in neuroblastoma. Cancer Res 1995, 55, 4664-4669.
3. Gehring M., Berthold F., Edler L., Schwab M., Amler L. C. The 1p deletion is not a reliable marker for the prognosis of patients with neuroblastoma. Cancer Res. 55:1995;5366-5369.
4. Caron H, van Sluis P, de Kraker J, et al. Allelic loss of chromosome 1p as a predictor of unfavorable outcome in patients with neuroblastoma. N Engl J Med 1996, 334, 225-230.
5. Maris JM, Kyemba SM, Rebbeck TR, et al. Familial predisposition to neuroblastoma does not map to chromosome band 1p36. Cancer Res 1996, 56, 3421-3425.
6. Collins F. S. Positional cloning moves from perditional to traditional. Nat Genet. 9:1995;347-350.
7. Bellefroid E. J., Lecocq P. J., Benhida A., Poncelet D. A., Belayew A., Martial J. A. The human genome contains hundreds of genes coding for finger proteins of the Kruppel type. DNA. 8:1989;377-387.
8. Haber DA, Buckler AJ, Glaser T, et al. An internal deletion within an 11p13 zinc finger gene contributes to the development of Wilms' tumor. Cell 1990, 61, 1257-1269.
9. Gessler M., Poustka A., Cavenee W., Neve R. L., Orkin S. H., Bruns G. A. Homozygous deletion in Wilms' tumours of a zinc-finger gene identified by chromosome jumping. Nature. 343:1990;774-778.
10. Call KM, Glaser T, Ito CY, et al. Isolation and characterization of a zinc finger polypeptide gene at the human chromosome 11 Wilms' tumor locus. Cell 1990, 60, 509-520.
11. Chen Z, Brand NJ, Chen A, et al. Fusion between a novel Kruppel-like zinc finger gene and the retinoic acid receptor-alpha locus due to a variant t(11;17) translocation associated with acute promyelocytic leukaemia. EMBO J 1993, 12, 1161-1167.
12. McGuire E. A., Hockett R. D., Pollock K. M., et al. The t(11;14)(p15;q11) in a T-cell acute lymphoblastic leukemia cell line activates multiple transcripts, including Ttg-1, a gene encoding a potential zinc finger protein. Mol Cell Biol. 9:1989;2124-2132.
13. Goddard A. D., Borrow J., Freemont P. S., Solomon E. Characterization of a zinc finger gene disrupted by the t(15;17) in acute promyelocytic leukemia. Science. 254:1991;1371-1374.
14. Miki T., Kawamata N., Hirosawa S., Aoki N. Gene involved in the 3q27 translocation associated with B-cell lymphoma, BCL5, encodes a Kruppel-like zinc-finger protein. Blood. 83:1994;26-32.
15. Kerckaert J. P., Deweindt C., Tilly H., et al. LAZ3, a novel zinc-finger encoding gene, is disrupted by recurring chromosome 3q27 translocations in human lymphomas. Nat Genet. 5:1993;66-70.
16. Bastard C, Deweindt C, Kerckaert JP, et al. LAZ3 rearrangements in non-Hodgkin's lymphoma: correlation with histology, immunophenotype, karyotype, and clinical outcome in 217 patients. Blood 1994, 83, 2423-2427.
17. Otsuki T, Yano T, Clark HM, et al. Analysis of LAZ3 (BCL-6) status in B-cell non-Hodgkin's lymphomas: results of rearrangement and gene expression studies and a mutational analysis of coding region sequences. Blood 1995, 85, 2877-2884.
18. Kinzler KW, Bigner SH, Bigner DD, et al. Identification of an amplified, highly expressed gene in a human glioma. Science 1987, 236, 70-73.
19. Wong A. J., Bigner S. H., Bigner D. D., et al. Increased expression of the epidermal growth factor receptor gene in malignant gliomas is invariably associated with gene amplification. Proc Natl Acad Sci USA. 84:1987;6899-6903.
20. Roberts W. M., Douglass E. C., Peiper S. C., Houghton P. J., Look A. T. Amplification of the gli gene in childhood sarcomas. Cancer Res. 49:1989;5407-5413.
21. Ruppert JM, Kinzler KW, Wong AJ, et al. The GLI-Kruppel family of human genes. Mol Cell Biol 1988, 8, 3104-3113.
22. Sugawara M., Scholl T., Ponath P. D., Strominger J. L. A factor that regulates the class II major histocompatibility complex gene DPA is a member of a subfamily of zinc finger proteins that includes a Drosophila developmental control protein. Mol Cell Biol. 14:1994;8438-8450.
23. Maris JM, Jensen SJ, Sulman EP, et al. Cloning, chromosomal localization, physical mapping, and genomic characterization of HKR3. Genomics 1996, 35, 289-298.
24. Biegel JA, White PS, Marshall HN, et al. Constitutional 1p36 deletion in a child with neuroblastoma. Am J Hum Genet 1993, 52, 176-182.
25. Van Roy N, Laureys G, Cheng NC, et al. 1;17 Translocations and other chromosome 17 rearrangements in human primary neuroblastoma tumors and cell lines. Genes Chromosom Cancer 1994, 10, 103-114.
26. Nakagawara A, Liu X, Ikegaki N, et al. Cloning and chromosomal localization of the human TRK-B Tyrosine Kinase Receptor Gene (NTRK2). Genomics 1995, 25, 538-546.
27. Reynolds CP, Tomayko MM, Donner L, et al. Biological classification of cell lines derived from human extra-cranial neural tumors. Prog Clin Biol Res 1988, 271, 291-306.
28. Ausubel FM, Brent R, Kingston RE, et al. (eds) Current Protocols in Molecular Biology. New York, Wiley, 1995.
29. Kroczek R. A., Siebert I. Optimization of Northern analysis by vacuum-blotting, RNA-transfer visualization, and ultraviolet fixation. Anal Biochem. 184:1990;90-95.
30. Heim RA, Kam-Morgan LN, Binnie CG, et al. Distribution of 13 truncating mutations in the neurofibromatosis 1 gene. Hum Mol Genet 1995, 4, 975-981.
31. Dib C, Faure S, Fizames C, et al. A comprehensive genetic map of the human genome based on 5,264 microsatellites. Nature 1996, 380, 152-154.
32. Larsen F., Gundersen G., Lopez R., Prydz H. CpG islands as gene markers in the human genome. Genomics. 13:1992;1095-1107.
33. Gardiner-Garden M., Frommer M. CpG islands in vertebrate genomes. J Mol Biol. 196:1987;261-282.
34. Abrink M., Aveskogh M., Hellman L. Isolation of cDNA clones for 42 different Kruppel-related zinc finger proteins expressed in the human monoblast cell line U-937. DNA Cell Biol. 14:1995;125-136.
35. Forrest S., Cotton R., Landegren U., Southern E. How to find all those mutations. Nat Genet. 10:1995;375-376.